Autonomix Medical (AMIX) Competitors $1.12 -0.06 (-5.08%) As of 02:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMIX vs. DRIO, IRIX, NXGL, NRXS, ALUR, IINN, DHAI, BTCY, NXL, and MHUAShould you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include DarioHealth (DRIO), IRIDEX (IRIX), NexGel (NXGL), NeurAxis (NRXS), Allurion Technologies (ALUR), Inspira Technologies OXY B.H.N. (IINN), DIH Holding US (DHAI), Biotricity (BTCY), Nexalin Technology (NXL), and Meihua International Medical Technologies (MHUA). These companies are all part of the "medical equipment" industry. Autonomix Medical vs. Its Competitors DarioHealth IRIDEX NexGel NeurAxis Allurion Technologies Inspira Technologies OXY B.H.N. DIH Holding US Biotricity Nexalin Technology Meihua International Medical Technologies DarioHealth (NASDAQ:DRIO) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation and profitability. Do analysts rate DRIO or AMIX? DarioHealth presently has a consensus target price of $40.00, suggesting a potential upside of 293.89%. Autonomix Medical has a consensus target price of $16.50, suggesting a potential upside of 1,373.21%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than DarioHealth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DarioHealth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Autonomix Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor DRIO or AMIX? In the previous week, DarioHealth and DarioHealth both had 5 articles in the media. Autonomix Medical's average media sentiment score of 0.70 beat DarioHealth's score of 0.22 indicating that Autonomix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DarioHealth 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Autonomix Medical 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in DRIO or AMIX? 33.4% of DarioHealth shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 11.2% of DarioHealth shares are held by insiders. Comparatively, 32.4% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk and volatility, DRIO or AMIX? DarioHealth has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -2.96, indicating that its stock price is 396% less volatile than the S&P 500. Which has preferable valuation and earnings, DRIO or AMIX? Autonomix Medical has lower revenue, but higher earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDarioHealth$27.04M17.09-$42.75M-$0.66-15.39Autonomix MedicalN/AN/A-$11.41M-$5.74-0.20 Is DRIO or AMIX more profitable? Autonomix Medical has a net margin of 0.00% compared to DarioHealth's net margin of -162.73%. DarioHealth's return on equity of -65.89% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets DarioHealth-162.73% -65.89% -39.03% Autonomix Medical N/A -172.93%-133.39% SummaryAutonomix Medical beats DarioHealth on 7 of the 13 factors compared between the two stocks. Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMIX vs. The Competition Export to ExcelMetricAutonomix MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.63M$6.91B$5.75B$9.84BDividend YieldN/A1.30%3.95%4.02%P/E Ratio-0.2026.3630.7626.60Price / SalesN/A55.64459.33120.41Price / CashN/A21.6137.7659.36Price / Book0.946.9210.036.70Net Income-$11.41M$176.42M$3.27B$265.68M7 Day Performance10.89%3.10%3.36%3.42%1 Month Performance-14.50%-1.77%4.58%1.09%1 Year Performance-90.26%9.53%44.38%23.94% Autonomix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMIXAutonomix Medical2.8469 of 5 stars$1.12-5.1%$16.50+1,373.2%-90.0%$6.63MN/A-0.201DRIODarioHealth1.3107 of 5 stars$0.44-2.2%$2.00+354.5%-43.5%$20.02M$27.04M-0.67200Stock SplitIRIXIRIDEX1.3865 of 5 stars$1.15-1.7%N/A-34.3%$19.54M$48.67M-3.48120Positive NewsNXGLNexGel1.6778 of 5 stars$2.39+3.5%N/A-13.7%$19.29M$8.69M-5.9710Gap UpNRXSNeurAxis2.6062 of 5 stars$2.36-4.8%$7.00+196.6%-22.7%$17.03M$3.22M-1.2819ALURAllurion Technologies2.4948 of 5 stars$2.26-4.9%$22.83+912.6%-85.2%$16.82M$32.11M-0.18501IINNInspira Technologies OXY B.H.N.3.1344 of 5 stars$1.23-1.2%$2.00+62.6%+5.5%$15.52MN/A0.0020Positive NewsHigh Trading VolumeDHAIDIH Holding US0.9333 of 5 stars$0.29-3.9%N/A-88.1%$13.73M$64.47M-0.97N/AGap UpHigh Trading VolumeBTCYBiotricityN/A$0.55-12.0%N/A+33.0%$13.70M$12.06M-0.5140News CoverageNXLNexalin Technology3.0306 of 5 stars$0.75-6.9%$5.00+567.8%-12.6%$13.04M$170K-0.993Positive NewsMHUAMeihua International Medical Technologies0.8207 of 5 stars$0.40-0.7%N/A-62.3%$12.79M$96.90M0.00620Gap Up Related Companies and Tools Related Companies DarioHealth Competitors IRIDEX Competitors NexGel Competitors NeurAxis Competitors Allurion Technologies Competitors Inspira Technologies OXY B.H.N. Competitors DIH Holding US Competitors Biotricity Competitors Nexalin Technology Competitors Meihua International Medical Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMIX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access